Testing Choices: From the standard to the extraordinary
Test | Test Name |
---|---|
9103U | Alfentanil Screen, Urine |
9145UC | Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9176B | Fentanyl and Metabolite Screen, Blood |
9176FL | Fentanyl and Metabolite Screen, Fluid |
9176SP | Fentanyl and Metabolite Screen, Serum/Plasma |
9176TI | Fentanyl and Metabolite Screen, Tissue |
9182B | Haloperidol Screen, Blood |
9182SP | Haloperidol Screen, Serum/Plasma |
9264B | Sufentanil Screen, Blood |
9264U | Sufentanil Screen, Urine |
9288B | Tramadol and Metabolite Screen, Blood |
9288FL | Tramadol and Metabolite Screen, Fluid |
9288SP | Tramadol and Metabolite Screen, Serum/Plasma |
9291H | Fentanyl Screen, Hair |
9329ME | Benzodiazepines Panel (Qualitative), Meconium |
9351UC | Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC | Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |